S

surgezirc.co.za

@surgezirc Wed, 11 Mar 2026 00:30:31

CK Life Sciences Establishes Sequencio Therapeutics to Advance Therapeutic Cancer Vaccines Development

HONG KONG SAR Media OutReach Newswire 10 March 2026 CK Life Sciences Intl., (Holdings) Inc. (CK Life Sciences or the Company, Stock Code: 0775) today announced the establishment of Sequencio Therapeutics (Sequencio), a wholly-owned subsidiary dedicated to advancing the Companys therapeutic cancer vaccine portfolio. The Third Pillar of a Strategic Reorganisation This The post CK Life Sciences Establishes Sequencio Therapeutics to Advance Therapeutic Cancer Vaccines Development appeared first on SurgeZirc SA.

read more

Other Headlines